Small Stocks BIG Returns

Timing Really is Everything: THLD, ATRN, RXII
/

January 18, 2025

/

04:14 AM PST

Small cap stocks Atrinsic, Inc. (ATRN), Threshold Pharmaceuticals, Inc. (THLD), and RXi Pharmaceuticals Corporation (RXII) are poked and prodded.

Shipping Stocks Showing Takeover Volume (NEWL, EGLE, HRZ, TBSI, DHT)
/

January 18, 2025

/

04:14 AM PST

This year is proving to be a record for mergers and activities with shipping stocks looking appealing for a number of factors/

Mullen Automotive (MULN) Surges 256%: What’s Behind the Explosive Rally?

June 4, 2025

/

10:54 AM PST

Mullen Automotive Inc. (NASDAQ: MULN), the embattled EV manufacturer, shocked investors today with a staggering 256% surge in its stock price. The rally comes amid a flurry of speculation, high trading volume, and renewed interest in small-cap EV plays.

Tuesday’s Small Caps to Watch (& Why): AUGT, TGC, and WGAT
/

January 18, 2025

/

04:34 AM PST

Small stocks Tengasco, Inc. (TGC), WorldGate Communications, Inc. (WGAT), and Augme Technologies Inc. (AUGT) are primed to be Tuesday’s wildest rides.

Chinese Stocks (GURE, SINO, UTA) Falling will Drag Australian Stocks Down
/

January 18, 2025

/

04:15 AM PST

Australia is tied to the Chinese Economy, with its stocks falling in tandem

Market Misperception May Offer Buying Opportunity for Pluristem
/

January 18, 2025

/

04:17 AM PST

As reported by Ray Dirks Pluristem Therapeutics (Nasdaq: PSTI ) made a major announcement on Monday, June 20th, but that was a weak week for the Stock market, so PSTI is still way undervalued at $2.98. PSTI entered into an Exclusive License Agreement with United Therapeutics (UTHR.nasdaq) for the use of Pluristem’s Placental eXpanded (PLX) cells to develop and commercialize a cell-based product for the Treatment of Pulmonary Hypertension (PH). Under the terms of the Agreement,